Description: EZ Cap Human IL-29 mRNA (m1Ψ, HA tag) is a specialized mRNA product designed for enhanced expression and stability, encoding human IL-29, a cytokine belonging to the type III interferon family. IL-29 plays a crucial role in modulating immune responses, with significant antiviral, anti-proliferative, and immunoregulatory properties. It activates the JAK-STAT signaling pathway through STAT1 and STAT2, and can either promote or inhibit tumor effects depending on the cell type. IL-29 also enhances the production of pro-inflammatory cytokines such as IL-6 and IL-8, and regulates the function of various immune cells, including monocytes, macrophages, and dendritic cells. Additionally, it has been implicated in the pathogenesis of inflammatory autoimmune diseases like rheumatoid arthritis, psoriasis, and systemic lupus erythematosus. This mRNA is modified with N1-methylpseudouridine (m1Ψ) to enhance translation efficiency and reduce immunogenicity, and includes an HA tag for easy detection and purification. It is a valuable tool for studying IL-29's mechanisms in immune regulation and its potential therapeutic applications in autoimmune and inflammatory conditions.
CAT: BRP-02628
Purity: ≥95% (Agarose Gel Electrophoresis)
Appearance: Colorless liquid
Concentration: 1.0 mg/mL